Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1119 Results

Title
Intervention Indication Therapeutic Area Year Actions
Secukinumab for moderate to severe plaque psoriasis in children aged 6 to less than 18 years old Secukinumab (Cosentyx; AIN457) Plaque psoriasis Dermatology 2019 View  |  Download
Secukinumab for Non-Radiographic Axial Spondyloarthritis – second or subsequent line Secukinumab (Cosentyx; AIN457) Spondyloarthritis Musculoskeletal System , Rheumatology 2018 View  |  Download
Seladelpar for primary biliary cirrhosis – second or subsequent line Seladelpar (MBX-8025; RWJ-800025) Primary biliary cholangitis (PBC) Hepatology 2017 View  |  Download
Selinexor for advanced or recurrent endometrial cancer - maintenance therapy Selinexor (KPT-330; Xpovio) Endometrial cancer Female Reproductive Cancer 2020 View  |  Download
Selinexor for advanced unresectable dedifferentiated liposarcoma Selinexor (KPT-330; Xpovio) Soft tissue sarcoma Sarcoma 2020 View  |  Download
Selinexor in addition to bortezomib and low-dose dexamethasone for relapsed or refractory multiple myeloma Bortezomib (Velcade; bortezomib mannitol boronic ester) , Dexamethasone (dexamethasone sodium metasulfobenzoate) , Selinexor (KPT-330; Xpovio) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2020 View  |  Download
Selinexor in combination with low-dose dexamethasone for penta-refractory multiple myeloma Dexamethasone (dexamethasone sodium metasulfobenzoate) , Selinexor (KPT-330; Xpovio) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2018 View  |  Download
Selonsertib for Non-alcoholic Steatohepatitis (NASH) Selonsertib (GS-4997) Non-alcoholic steatohepatitis (NASH) Hepatology 2018 View  |  Download
Selpercatinib for advanced thyroid cancer with RET alterations Selpercatinib (LOXO-292; LY3527723) Medullary thyroid cancer (MTC) , Thyroid cancer Head and Neck Cancer , Oncology 2019 View  |  Download
Selpercatinib for metastatic RET fusion-positive non-small cell lung cancer Selpercatinib (LOXO-292; LY3527723) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2019 View  |  Download
1 2 89 90 91 92 93 111 112
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications